Science

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

Gerry Hanna/X

May 1, 2025, 10:14

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

Gerry Hanna, Marie Curie Chair of Clinical Oncology at Trinity College Dublin, shared on X:

“Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?”

This short paper in today’s NEJM suggests that routine scanning/surveillance is not beneficial and maybe harmful in some cases. Food for thought…”

Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients?

Authors: H. Gilbert Welch and Lesly A. Dossett

You can Read the Full Article on The New England Journal of Medicine.

Gerry Hanna: Routine Scanning/surveillance for Cancer Metastases is not Beneficial and Maybe Harmful in Some Cases

More posts featuring Gerry Hanna.

cancer cancer metastases clinical oncology fight against cancer Gerry Hanna Global fight against cancer H Gilbert Welch Lesly A. Dossett Marie Curie Chair NEJM OncoDaily Oncology patients The New England Journal of Medicine. Trinity College Dublin

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening